Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Middle Meningeal Artery Embolization for Migraine
NCT07633067Not yet recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- Jun 2026
- Primary completion
- Dec 2028
01
Overview
Randomised, double-blind trial in migraine (3 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoint: Migraine attack frequency at 180 days. Planned start Jun 2026; status: not yet recruiting.
02
Conditions
migraine
Beyond the preview
Go deeper on NCT07633067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07633067.